ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Atento SA

Atento SA (ATTO)

0.4715
0.00
(0.00%)
Closed March 29 04:00PM
0.00
0.00
(0.00%)

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.4715
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.4248 52 Week Range 3.50
Market Cap
Previous Close
0.4715
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
15,452,000
Dividend Yield
-
PE Ratio
-0.02
Earnings Per Share (EPS)
-19.13
Revenue
1.41B
Net Profit
-295.58M

About Atento SA

Atento S.A is a provider of customer relationship management (CRM) and business process outsourcing (BPO) services & solutions in Latin America. It offers a range of front and back-end services, including sales, customer care, collections, back-office, and technical support services. Atento provides... Atento S.A is a provider of customer relationship management (CRM) and business process outsourcing (BPO) services & solutions in Latin America. It offers a range of front and back-end services, including sales, customer care, collections, back-office, and technical support services. Atento provides its services and solutions through digital channels, which include SMS, email, chats, social media and apps, and others, as well as through voice and in-person. Its geographical segments are Brazil, America, and EMEA (Europe, the Middle East, and Africa). Show more

Sector
Communications Services, Nec
Industry
Communications Services, Nec
Website
Headquarters
Luxembourg City, Luxembourg, Lux
Founded
1970
Atento SA is listed in the Communications Services sector of the New York Stock Exchange with ticker ATTO. The last closing price for Atento was $0.47. Over the last year, Atento shares have traded in a share price range of $ 0.4248 to $ 3.50.

Atento currently has 15,452,000 shares outstanding. The market capitalization of Atento is $7.26 million. Atento has a price to earnings ratio (PE ratio) of -0.02.

ATTO Latest News

Atento announces the successful implementation of its financial restructuring and unveils new business strategy leading the way to BTO (Business Transformation Outsourcing)

Atento announces the successful implementation of its financial restructuring and unveils new business strategy leading the way to BTO (Business Transformation Outsourcing) PR Newswire MADRID...

Atento appoints Álvaro Badiola Guerra as Group CFO

Atento appoints Álvaro Badiola Guerra as Group CFO PR Newswire SÃO PAULO, Oct. 26, 2023 His appointment as Chief Financial Officer will drive forward the company's financial strategy following...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of...

Atento announces drawdown of $17 million in tranche 2 funding under its new interim financing

Atento announces drawdown of $17 million in tranche 2 funding under its new interim financing PR Newswire NEW YORK, Aug. 1, 2023 Tranche 2 upsized by $7 million to provide enhanced financial...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
52-1.6185-77.44019138762.093.50.42488094392.4070733CS
156-20.5885-97.761158594521.06320.42481297534.3431791CS
260-2.9385-86.17302052793.41320.42481094444.05634789CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 22.08
(364.84%)
31.9M
NXLNexalin Technologies Inc
$ 1.50
(92.31%)
11.67M
CEROCERo Therapeutics Holdings Inc
$ 3.112
(90.92%)
24.08M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
KYCHKeyarch Acquisition Corporation
$ 12.30
(75.58%)
196.62k
BOLDBoundless Bio Inc
 14.25
(-76.24%)
767.63k
PMECPrimech Holdings Ltd
$ 1.2999
(-66.50%)
8.28M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.1816
(-44.45%)
21.92M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
NBSTWNewbury Street Acquisition Corporation
$ 0.042279
(-38.28%)
1.75k
NKLANikola Corporation
$ 1.035
(13.85%)
163.84M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
MARAMarathon Digital Holdings Inc
$ 22.56
(2.22%)
86.14M
AKANAkanda Corporation
$ 0.1166
(-29.29%)
80.34M

Discussion

View Full Feed
sirant sirant 2 minutes ago
GOOD MORNING EVERYONE

GO $MCIC
MCIC
lflhdy lflhdy 2 minutes ago
Opinions? Did IDA already exercise their option and not reported to OTC markets?
IQST
tulla236a tulla236a 2 minutes ago
for someone who was looking 100 years, 25 is a gift. they will let him out early to keep his mouth shut.
AMC
Pharma Sleuth Pharma Sleuth 2 minutes ago
Lol. Did employees already buy the shares? Or are they going to be given them when the company is sold? To reward them?

That's the question. Nasrats shares were already known. This is cleaning everything up. Which is needed for a merger, acquisition or buyout.
ELTP
MightyX MightyX 3 minutes ago
I understand how the OTC economy works..money coming in is less and less especially now with crypto and exchange IPO’s/SPAC’s, where the more money is going in, the more money can be taken out. For legacy OTC traders, the OTC is a dying economy.
TPTW
Number sleven Number sleven 3 minutes ago
Captain, What are the generic companies trying to achieve by filing these suits? Teva has been importing a staggering amount of IPE. They aren't selling much finished product. How exactly would a win benefit them?
Sleven,
AMRN
TexasMarvL TexasMarvL 3 minutes ago
Versea Health hired Stephen Gizzi as a regional sales manager for the New York metro area 5 months ago.

Yesterday Verséa Ophthalmics added a new paying customer from New York. Funny how that works.

Verséa Ophthalmics and Verséa Health are building a sales staff that
AXIM
astro2 astro2 3 minutes ago
Probably what you were on when you hit the sell button in 2021
LWLG
glenn1919 glenn1919 3 minutes ago
MULN......NTRB......REKR.........https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=NTRB&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=REKR&p=D&yr=0&mn=2&dy=12&id=p84071410134
MULN NTRB REKR
I-Glow I-Glow 4 minutes ago
Then prove there is a great deal of accumulation - just because Druggie says it and you co-sign it is more meaningless pumping.

The Form 10 won't be effective until 2026 - and it very doubtful that FINRA will ever process a Form 10. Sharp has Zero credibility and can't be trusted.
GVSI
Real McCoy Real McCoy 4 minutes ago
Are financials due today?
VERB
pete807 pete807 4 minutes ago
At the very least TDS will wither a bit when they choose 87 at the pump.
Me thinks the least narcissistic guy in my lifetime was J Carter who could not win a second term so I must agree
tough, strong effective executives generally are not likable people, but are really good to do bus
plexrec plexrec 4 minutes ago
" if we do have the wonder drug, he needs to be immediately removed for his ridiculous management that doesn't rise to the position of CEO."--the one and only reason for our wonderful Share Price--what a Eff'n pity--check out our SP chart---Market at all-time highs---and where do we sit---thanks to
AVXL
HGilS HGilS 4 minutes ago
If you ask eatman, he would replace the $ sign with cents sign - if you ask me, I would add a zero on the right of each digit...
ELTP
namtae namtae 4 minutes ago
Thats almost 130,000,000 shares being registered, meaning unrestricted and available for sale

Theres no way to spin this as good or neutral news. It potentially adds great downside pressure to the stock price.

Agree that the CEO is gonna hold but what about all the ot
ELTP
Guido2 Guido2 4 minutes ago
Agree, but the payroll argument is lost on those who never worked for a living.
FNMA
burdbasket burdbasket 5 minutes ago
He isn’t going away. He is a narcissist. One of the main basic traits of a narcissist is that the disease is latent (hidden); that is, a narcissist doesn’t know nor can he/she be convinced that they are a narcissist. That’s why they appear to be brain-dead. Crow is classic narcissism.
IGPK
Groveman1 Groveman1 5 minutes ago
Thanks Lucky, This whole thing does not sound right. ShareHolders are stuck waiting, with no say, Caren Currier and Acropolis are impossible to Contact. There has to be something Illegal about all this.
LLBO
glenn1919 glenn1919 5 minutes ago
BDRX......RZLT.......MULN..................................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=RZLT&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=BDRX&p=D&yr=0&mn=2&dy=12&id=p84071410134
BDRX MULN RZLT
al44 al44 5 minutes ago
Friday's Energy Absurdity: UK Regulator Orders an All-Electric North Sea

David Blackmon
Mar 29, 2024

Honestly, what are you even going to say about this one, other than these people are utterly insane.


The Telegraph reports that the North S
Meangene818 Meangene818 5 minutes ago
It’s great to pay $15 for a $5 burger? Can’t fix stupid!!
DJT
Mufaso Mufaso 6 minutes ago
CLF- I find it to be very bullish for a company when a short seller changes their mind on a stock from sell to buy. GLJ Research is a small firm that makes short and long recommendations (mostly short from what I can see on their website.) Apparently Barron's took note and had this piece yesterda
CLF
pinhigh pinhigh 6 minutes ago
Fresh off the opioid crisis....society finds itself in a desperate situation. Is it any wonder that the NOPAINACT is getting set for implementation? Biel's Actipatch checks all the boxes for participation! Truth be known....the Act should already be underway.
BIEL
Oleblue Oleblue 6 minutes ago
TECK is near an all time high and OBV is in a nice uptrend.

https://api.wsj.net/api/kaavio/charts/big.chart?nosettings=1&symb=teck&uf=32&type=4&size=4&sid=46911&style=330&freq=2&entitlementtoken=0c33378313484ba9b46b8e24ded87dd6&time=13&rand=1362072064&compidx=aaaaa%3a0&ma=2&maval=8&lf
TECK

Your Recent History

Delayed Upgrade Clock